# George T. Grossberg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/george-t-grossberg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 15,664 |
| Field | Dementia and Cognitive Impairment Research |
| h-index | 58 |
| i10-index | 181 |
| Last Known Institution | University of Missouri–St. Louis |
| OpenAlex ID | https://openalex.org/A5008190526 |
| ORCID iD | 0000-0002-1493-3931 |
| Works | 418 |

## Researcher papers

- [The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease](https://scholariq.org/papers/the-cholinergic-system-in-the-pathophysiology-and-treatment-of-alzheimer-s/)
- [Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil](https://scholariq.org/papers/memantine-treatment-in-patients-with-moderate-to-severe-alzheimer-disease/)
- [Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders](https://scholariq.org/papers/proposed-diagnostic-criteria-for-apathy-in-alzheimer-s-disease-and-other/)
- [Management of agitation and aggression associated with Alzheimer disease](https://scholariq.org/papers/management-of-agitation-and-aggression-associated-with-alzheimer-disease/)
- [Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease:](https://scholariq.org/papers/cholinesterase-inhibitors-for-the-treatment-of-alzheimer-s-disease/)
- [Management of behavioral problems in Alzheimer's disease](https://scholariq.org/papers/management-of-behavioral-problems-in-alzheimer-s-disease/)
- [The Evolution of Psychiatric Symptoms in Alzheimer's Disease: A Natural History Study](https://scholariq.org/papers/the-evolution-of-psychiatric-symptoms-in-alzheimer-s-disease-a-natural-history/)
- [Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Consensus Conference](https://scholariq.org/papers/brain-health-the-importance-of-recognizing-cognitive-impairment-an-iagg/)
- [Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis](https://scholariq.org/papers/practical-recommendations-for-timely-accurate-diagnosis-of-symptomatic-alzheimer/)
- [A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule](https://scholariq.org/papers/a-six-month-double-blind-randomized-placebo-controlled-study-of-a-transdermal/)
- [Toxic Environmental Risk Factors for Alzheimer’s Disease: A Systematic Review](https://scholariq.org/papers/toxic-environmental-risk-factors-for-alzheimer-s-disease-a-systematic-review/)

## Researcher topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Healthcare Decision-Making and Restraints](https://scholariq.org/topics/healthcare-decision-making-and-restraints/)

## Researcher university

- [University of Missouri–St. Louis](https://scholariq.org/institutions/university-of-missouri-st-louis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.